Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013, Article ID 614242, 6 pages
Research Article

Comparison of a Multiple Daily Insulin Injection Regimen (Glargine or Detemir Once Daily Plus Prandial Insulin Aspart) and Continuous Subcutaneous Insulin Infusion (Aspart) in Short-Term Intensive Insulin Therapy for Poorly Controlled Type 2 Diabetes Patients

1The Department of Internal Medicine, The Affiliated Hospital of Medical College, Qingdao University, Qingdao 266100, China
2Department of Endocrinology, Key Laboratory of Endocrinology, Fujian Provincial Hospital, Fujian Medical University, North Branch of Fujian Provincial Hospital, Fujian Provincial Geriatric Hospital, Fuzhou 350001, China

Received 16 May 2012; Revised 27 March 2013; Accepted 13 April 2013

Academic Editor: Anil K. Agarwal

Copyright © 2013 Wen-shan Lv et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [6 citations]

The following is the list of published articles that have cited the current article.

  • Guoyue Yuan, Dong Wang, Ling Yang, Libin Zhou, Chaoming Mao, Jue Jia, Caili Zhang, Shuqin Yu, Sijing Dong, Jingjing Ye, Tianyi Zhu, Bingqian Tang, and Weiyun Qian, “Safety and efficacy of sitagliptin in combination with transient continuous subcutaneous insulin infusion (CSII) therapy in patients with newly diagnosed type 2 diabetes,” Endocrine Journal, vol. 61, no. 5, pp. 513–521, 2014. View at Publisher · View at Google Scholar
  • Kjeld Hermansen, Mette Bohl, and Anne Grethe Schioldan, “Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience,” Drugs, vol. 76, no. 1, pp. 41–74, 2016. View at Publisher · View at Google Scholar
  • Heng Wan, Defu Zhao, Jie Shen, Lu Lu, Tong Zhang, and Zhi Chen, “Comparison of the Effects of Continuous Subcutaneous Insulin Infusion and Add-On Therapy with Sitagliptin in Patients with Newly Diagnosed Type 2 Diabetes Mellitus,” Journal of Diabetes Research, vol. 2016, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • W. Gu, Y. Liu, Y. Chen, W. Deng, X. Ran, L. Chen, D. Zhu, J. Yang, J. Shin, S.W. Lee, T.L. Cordero, and Y. Mu, “Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China: Time to reach target glucose,” Diabetes & Metabolism, 2017. View at Publisher · View at Google Scholar
  • Feng-fei Li, Bing-li Liu, Hong-hong Zhu, Ting Li, Wen-li Zhang, Xiao-fei Su, Jin-dan Wu, Xue-qin Wang, Ning Xu, Wei-Nan Yu, Qun Yuan, Guan-cheng Qi, Lei Ye, Kok-Onn Lee, and Jian-hua Ma, “Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men,” Journal of Diabetes Research, vol. 2017, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  • Feng-fei Li, Ying Zhang, Wen-li Zhang, Xiao-mei Liu, Mao-yuan Chen, Yi-xuan Sun, Xiao-fei Su, Jin-dan Wu, Lei Ye, and Jian-hua Ma, “Male Patients with Longstanding Type 2 Diabetes Have a Higher Incidence of Hypoglycemia Compared with Female Patients,” Diabetes Therapy, 2018. View at Publisher · View at Google Scholar